These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 23697916)
21. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502 [TBL] [Abstract][Full Text] [Related]
22. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590 [TBL] [Abstract][Full Text] [Related]
23. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate. Chakraborty S; Shukla D; Vuddanda PR; Mishra B; Singh S J Pharm Pharmacol; 2011 Jun; 63(6):774-9. PubMed ID: 21585374 [TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique. Negi JS; Chattopadhyay P; Sharma AK; Ram V Arch Pharm Res; 2014 Mar; 37(3):361-70. PubMed ID: 23695866 [TBL] [Abstract][Full Text] [Related]
25. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. Vivek K; Reddy H; Murthy RS AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544 [TBL] [Abstract][Full Text] [Related]
26. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations. Yedurkar P; Dhiman MK; Petkar K; Sawant K J Microencapsul; 2012; 29(2):126-37. PubMed ID: 22047549 [TBL] [Abstract][Full Text] [Related]
27. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation. Dudhipala N; Janga KY Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147 [TBL] [Abstract][Full Text] [Related]
28. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Ji H; Tang J; Li M; Ren J; Zheng N; Wu L Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628 [TBL] [Abstract][Full Text] [Related]
29. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
30. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats. Thirupathi G; Swetha E; Narendar D Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936 [TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818 [TBL] [Abstract][Full Text] [Related]
32. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Chokshi NV; Khatri HN; Patel MM Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392 [TBL] [Abstract][Full Text] [Related]
33. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization. Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427 [TBL] [Abstract][Full Text] [Related]
34. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method. Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624 [TBL] [Abstract][Full Text] [Related]
35. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery. Rawat MK; Jain A; Mishra A; Muthu MS; Singh S Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120 [TBL] [Abstract][Full Text] [Related]
36. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. Makwana V; Jain R; Patel K; Nivsarkar M; Joshi A Int J Pharm; 2015 Nov; 495(1):439-446. PubMed ID: 26367780 [TBL] [Abstract][Full Text] [Related]
37. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Ye J; Wang Q; Zhou X; Zhang N Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182 [TBL] [Abstract][Full Text] [Related]
38. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles. Das S; Ng WK; Tan RB Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790 [TBL] [Abstract][Full Text] [Related]
39. Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation. Liu D; Pan H; He F; Wang X; Li J; Yang X; Pan W Int J Nanomedicine; 2015; 10():6425-34. PubMed ID: 26508852 [TBL] [Abstract][Full Text] [Related]
40. Studies on formulation development of mouth dissolving tablets of Carvedilol. Pokharkar V; Dhar S; Mandpe L Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]